Global Leading Market Research Publisher QYResearch announces the release of its latest report “Compression Stockings for Pregnancy – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Compression Stockings for Pregnancy market, including market size, share, demand, industry development status, and forecasts for the next few years.
For obstetricians, midwives, and expectant mothers navigating the physiological challenges of pregnancy, the critical need is not merely symptom relief but a clinically validated, non-invasive intervention that prevents the onset of chronic venous insufficiency. Compression stockings for pregnancy directly address this requirement by applying precise, graduated compression to the lower extremities, counteracting the venous hypertension and circulatory stasis induced by hormonal changes and the expanding gravid uterus. The global market was valued at USD 2,507 million in 2025 and is projected to reach USD 3,481 million by 2032, advancing at a compound annual growth rate of 4.9%.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6086628/compression-stockings-for-pregnancy
This steady growth trajectory reflects a structural shift in maternal healthcare, where compression hosiery is transitioning from a reactive hospital-dispensed medical device into a proactively purchased, premium consumer health product embedded within broader maternity wellness regimens.
Product Definition and Clinical Compression Technology
Compression stockings for pregnancy are specially engineered hosiery garments that apply graduated pressure to the legs, ankles, and feet of pregnant individuals to improve blood circulation, reduce edema and swelling, and prevent venous disorders including varicose veins and deep vein thrombosis. The defining technical characteristic is the pressure gradient—highest at the ankle and progressively decreasing up the leg—which mechanically supports the venous valves and calf muscle pump to facilitate venous return against gravity.
The market segments by compression level into clinically defined categories: Level 1 Low Pressure (15-20 mmHg), which provides prophylactic support for daily comfort and mild swelling; Level 2 Medium Pressure (20-30 mmHg), the most commonly prescribed range for moderate varicose veins, pronounced edema, and post-surgical recovery; and Level 3 High Pressure (30-40 mmHg) and Special Pressure grades for severe chronic venous insufficiency and advanced lymphatic conditions requiring specialist fitting. This medical-grade stratification distinguishes authentic compression hosiery from generic “support tights” and creates regulatory barriers that protect established manufacturers.
Exclusive Observation: The Bifurcation Between Clinical and Lifestyle Markets
An underappreciated structural dynamic in the compression stockings for pregnancy market is the accelerating divergence between two distinct demand profiles, each with fundamentally different product requirements, distribution channels, and competitive dynamics.
The clinical-grade segment, concentrated in the Level 2 and Level 3 compression categories, operates within a process-controlled manufacturing paradigm. These medical devices must comply with stringent regulatory frameworks—FDA 510(k) clearance in the United States, CE marking under EU Medical Device Regulation 2017/745, and equivalent certifications in other jurisdictions—requiring validated compression performance, documented biocompatibility, and quality management systems certified to ISO 13485. European manufacturers including Bauerfeind, Sigvaris, Medi, Juzo, and BSN Medical have historically dominated this segment, leveraging decades of clinical validation, established relationships with prescribing physicians and hospital procurement systems, and proprietary knitting technologies that ensure precise, durable compression gradients maintained across thousands of wear-wash cycles.
The lifestyle wellness segment, concentrated in the Level 1 category and fashion-forward maternity compression products sold through online channels, follows a model closer to discrete manufacturing of consumer goods. Brands including Pretty Legs Hosiery, Design Veronique, and Marena Group compete on aesthetic design, comfort features, price accessibility, and e-commerce distribution efficiency. This segment is experiencing faster growth driven by younger, digitally-native expectant mothers who discover compression products through social media platforms and influencer recommendations. The channel segmentation between Online Sales and Offline Sales reflects this dual-market structure: offline channels—hospital pharmacies, medical supply stores, and specialty maternity boutiques—remain dominant for clinically prescribed compression grades, while online sales channels are capturing disproportionate growth in the lifestyle and wellness-oriented subcategories.
The 2025 Medical Compression Retail Revolution
A transformative development reshaping the market occurred in 2025 with the opening of the United Kingdom’s first medical compression concept store, launched by Sigvaris Group in Braintree. The “Made to Move You” retail space represents a deliberate strategy to bridge the clinical-lifestyle divide, offering certified compression products in a boutique retail environment that eliminates the clinical sterility traditionally associated with medical hosiery. The store features trained compression therapists conducting complimentary leg health assessments, professional fitting services, and a curated selection of aesthetically designed compression garments. This retail innovation addresses the persistent adoption barrier of product stigmatization, where patients historically associated compression stockings with geriatric care rather than proactive maternal wellness.
Concurrently, JOBST (an Essity brand) announced a strategic retail partnership in April 2025 with a leading compression retailer to launch a new Wellness and Maternity collection, explicitly targeting the maternity segment with fashionable designs that meet medical compression specifications. This convergence of clinical credibility with consumer-centric retail experience is reshaping competitive dynamics, compelling traditional medical device manufacturers to invest in direct-to-consumer engagement capabilities while pressuring fashion-oriented entrants to substantiate their compression claims with clinical evidence.
The E-Commerce Disruption and Professional Endorsement Balance
Online sales channels are transforming market access, particularly for the Level 1 and Level 2 categories where self-measurement is more feasible and lower compression grades reduce fitting risk. Direct-to-consumer brands leverage digital sizing tools, virtual consultation services, and subscription models offering scheduled replacement of compression garments worn daily—which require replacement every three to six months as elastic fibers fatigue. However, the market retains a critical professional gatekeeping function. Obstetricians, midwives, and lymphedema therapists remain the primary prescribers and recommenders for higher compression grades, and improper self-sizing of Level 2 or Level 3 garments can result in ineffective compression or, conversely, tourniquet-like constriction with adverse circulatory effects.
The competitive landscape features a blend of established European medical compression specialists, global diversified healthcare companies—3M, Medtronic (Covidien), Paul Hartmann—and emerging Asian manufacturers including Zhende Medical Group, Maizi, and Okamoto Corporation that are scaling production capacity and pursuing international regulatory certifications. Japanese manufacturer Toko is notable for leveraging textile engineering expertise developed in athletic compression wear to create maternity-specific products with enhanced moisture management and extended wear comfort.
Conclusion
The compression stockings for pregnancy market, valued at USD 2.5 billion in 2025 and projected to approach USD 3.5 billion by 2032, occupies a strategically valuable position at the intersection of medical device regulation, maternal health advocacy, and consumer wellness retail. Competitive advantage will accrue to manufacturers that successfully bridge the clinical-lifestyle divide—delivering products that combine medically validated graduated compression performance with the aesthetic design, comfort features, and accessible retail experiences that modern expectant mothers demand. As the market continues its measured but resilient growth trajectory, the integration of professional clinical endorsement with direct-to-consumer engagement will define the winning strategies in this specialized, trust-intensive healthcare segment.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
